Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Astrazeneca Pharma India Ltd
Industry : Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value(
)
506820
INE203A01020
271.74
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
ASTRAZEN
138.16
17784.38
EPS(TTM)
Face Value(
)
Div & Yield %:
51.49
2
0.34
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Sales Turnover
1295.53
1002.97
805.60
813.56
831.81
728.29
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1295.53
1002.97
805.60
813.56
831.81
728.29
Other Income
51.23
26.10
14.76
12.84
12.99
16.29
Stock Adjustments
33.77
48.86
-14.47
-2.95
39.21
1.38
Total Income
1380.53
1077.93
805.89
823.45
884.01
745.96
EXPENDITURE :
Raw Materials
628.33
408.84
297.49
292.00
344.44
232.51
Power & Fuel Cost
4.87
5.54
8.10
7.37
7.72
8.27
Employee Cost
241.45
259.10
230.21
219.54
216.70
197.40
Other Manufacturing Expenses
14.38
13.79
8.05
9.11
9.04
9.83
Selling & Administrative Expenses
234.33
185.72
145.09
129.72
157.18
198.14
Miscellaneous Expenses
21.49
53.95
16.01
17.40
15.24
12.22
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1144.85
926.94
704.95
675.14
750.32
658.37
Operating Profit
235.68
150.99
100.94
148.31
133.69
87.59
Interest
1.20
0.63
0.95
1.09
1.14
0.00
Gross Profit
234.48
150.36
99.99
147.22
132.55
87.59
Depreciation
14.94
16.26
16.95
20.13
18.58
14.92
Profit Before Tax
219.54
134.10
83.04
127.09
113.97
72.67
Tax
58.93
38.30
22.63
34.83
31.51
16.68
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
-0.90
-3.49
-1.19
-1.04
10.25
1.54
Reported Net Profit
161.51
99.29
61.60
93.30
72.21
54.45
Extraordinary Items
12.45
-26.96
2.05
1.58
0.18
0.04
Adjusted Net Profit
149.06
126.25
59.55
91.72
72.03
54.41
Adjustment below Net Profit
1.00
-2.61
-1.74
3.43
-5.56
-0.60
P & L Balance brought forward
455.64
378.96
324.10
232.37
168.22
114.37
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
40.00
20.00
5.00
5.00
2.50
0.00
P & L Balance carried down
578.15
455.64
378.96
324.10
232.37
168.22
Dividend
0.00
0.00
5.00
5.00
2.50
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
1200.00
800.00
500.00
100.00
50.00
0.00
Dividend Per Share(Rs)
24.00
16.00
10.00
2.00
1.00
0.00
Earnings Per Share-Unit Curr
64.60
39.72
24.64
37.32
28.88
21.78
Earnings Per Share(Adj)-Unit Curr
64.60
39.72
24.64
37.32
28.88
21.78
Book Value-Unit Curr
284.77
235.48
204.56
182.47
145.78
120.32
Book Value(Adj)-Unit Curr
284.77
235.48
204.56
182.47
145.78
120.32